MedTrace Logo

Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases

NCT04929002 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-08-11

No results posted yet for this study

Summary

The project will use carbon-13 magnetic resonance spectroscopy to assess whether high glycogen levels in skeletal muscle of patients with Glycogen Storage Diseases is a prelude for muscle damage.

Patients with Glycogen Storage Diseases will be examined using carbon-13 MR-spectroscopy to quantify the glycogen levels in lumbar, thigh and calf-muscles. The pattern of glycogen concentration will be compared to the pattern of muscle atrophy found in the literature.

Conditions

  • Glycogen Storage Disease
  • McArdle Disease
  • Pompe Disease (Late-onset)

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Danish Research Center for Magnetic Resonance

    collaborator UNKNOWN

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-10
Primary Completion
2028-05-31
Completion
2028-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04929002 on ClinicalTrials.gov